M.R. Rakhmatulina

FSBI «State Research Center of Dermatology and Cosmetology» of RMPH, Moscow
The article highlights the issues of management of patients with the most common bacterial sexually transmitted infections - gonococcal and chlamydial infections. The main clinical manifestations of diseases, features of course of complicated and extragenital forms of infection are discussed; the modern methods of diagnosis, indications for examination of patients, and schemes of therapy of gonococcal and chlamydial infections are presented.


  1. CDC. Sexually Transmitted Diseases Surveillance 2012. Atlanta: US Department of Health and Human Services; 2015; avaliable at:
  2. World Health Organization (WHO), Department of Reproductive Health and Research: Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. Geneva: WHO; 2012. Р. 1–36. Available at: (Accessed: March 30, 2014).
  3. Рахматулина М.Р., Соколовский Е.В, Фриго Н.В. Федеральные клинические рекомендации по ведению больных гонококковой инфекцией (Национальные клинические рекомендации)
  4. Дерматовенерология. Национальное руководство / Под ред. Ю.К. Скрипкина, Ю.С. Бутова, О.Л. Иванова. М., 2011. 1021 с.
  5. Bignell C., Unemo M. European Guideline on the Diagnoses and Treatment of Gonorrhoeae in Adults. Available at:
  6. Sherrard J., Barlow D. Gonorrhoea in men: clinical and diagnostic aspects. Genitour. Med. 1996;72:422–26.
  7. Barlow D., Phillips I. Gonorrhoea in women: diagnostic, clinical and laboratory aspects. Lancet. 1978;1:761–64.
  8. Рахматулина М.Р., Соколовский Е.В, Малова И.О., Савичева А.М., Иванов А.М. Федеральные клинические рекомендации по ведению больных хламидийной инфекцией (Национальные клинические рекомендации)
  9. Cook R.L., Hutchison S.L., Ostergaard L., Braithwaite R.S., Ness R.B. Systematic Review: Non-invasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Ann. Internal. Med. 2005;142:914–25.
  10. Van Dyck E., Ieven M., Pattyn S., Van Damme L., Laga M. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by enzyme immunoassay, culture and three nucleic acid amplification tests. Journal of Clinical Microbiology. 2001;39:1751–56.
  11. Рахматулина М.Р., Барышков К.В., Абудуев Н.К. Особенности клинических проявлений гонококковой инфекции и тактика терапии заболевания с учетом антибиотикочувствительности N. go-norrhoeae в Архангельской области. Вестник дерматологии и венерологии. 2014;(6):100–06.
  12. Рафальский В.В., Довгань Е.В. Подходы к рациональному выбору антимикробной терапии гонококковой инфекции: значение данных по антибиотикорезистентности. Клиническая дерматология и венерология 2008;6:4–14.
  13. Backhaus A., Tinzl J. Cefixim tharapie bei Patienten mit nachgewiesener Gonorrh. Infect. 1990;18:145–46.
  14. Kuhlwein A., Nies B. Efficacy and safety of a 400mg single dose of oral cefixime in the treatment of uncomplicated gonorrhea. Advan. Experim. Clin.Chemother. 1988;1:49–52.
  15. Hook E.W., Maccormack W.M., Martin D., Jones R.B., Bean K., Maroli A.N. Comparison of Single-Dose Oral Grepafloxacin with Cefixime for Treatment of Uncomplicated Gonorrhea in Men. Antimicrob. Agent. Chemother. 1997;41(8):1843–45.
  16. Ramus R.M., Sheffield J.S., Mayfield J.A., Wendel G.D.Jr. A randomized trial that compared oral cefixime and intramuscular ceftriaxone for the treatment of gonorrhea in pregnancy. Am. J. Obstet. Gynecol. 2001;185:629–32.
  17. Brocklehurst P. Antibiotics for gonorrhoea in pregnancy Cochrane Database Syst. Rev. 2000;(2):CD000098.
  18. Рафальский В.В., Крикова А.В., Довгань Е.В. Место доксициклина в терапии инфекций: значение новых лекарственных форм. Вестник практического врача. Спецвыпуск 1. 2014:3–6.
  19. Lau C.Y., Qureshi A.K. Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials. Sex. Transm. Dis. 2002;29(9):497–502.
  20. Kong F.Y.S. et al. Azithromycin Versus Doxycycline for theTreatment of Genital Chlamydia Infection: A Meta-analysis of Randomized Controlled Trials. Clin. Infect. Dis. 2014;59(2):193–205.
  21. Steedman N.M., McMillan A. Treatment of asymptomatic rectal Chlamydia trachomatis: is single-dose azithromycin effective? Intern. J. STD AIDS. 2009;20:16–8.
  22. Magbanua J.P., Goh B.T., Michel C.E., Aguirre-Andreasen A., Alexander S., Ushiro-Lumb I., et al. Chlamydia trachomatis variant not detected by plasmid based nucleic acid amplification tests: molecular characterisation and failure of single dose azithromycin. Sex. Transm. Infect. 2007;83:339–43.
  23. Labro M.T., Babin-Chevaye C. Synergistic interaction of josamycin with human neutrophils bactericidal function in vitro. J. Antimicrob. Chemother. 1989;24(5):731–40.
  24. Czeizel A.E., Rockenbauer M., Olsen J., Sоren-sen H.T. A case control teratological study of spiramycin, roxithromycin, oleadomycin and josamycin. Acta Obstet. Gynecol. Scand. 2000;79(3):234–37.

About the Autors

M.R. Rakhmatulina – Doctor of Medical Sciences, Deputy Director for Research and Clinical Work FSBI "State Research Center of Dermatology and Cosmetology" of RMPH; e-mail:

Similar Articles

Бионика Медиа